Rilonacept (Arcalyst) for Recurrent Pericarditis

Type: drug

Status: FDA Approved

Developer: Kiniksa Pharmaceuticals

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026